HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

GSK 1070916

an antineoplastic agent with aurora B/C kinase inhibitory activity
Also Known As:
4-(3-(4-N,N-dimethylcarbamylaminophenyl)-1-ethyl-1H-pyrazol-4-yl)-2-(3-(dimethylaminomethyl)phenyl)-1H-pyrrolo(2,3-b)pyridine; GSK-1070916; GSK1070916
Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Oleykowski, Catherine A: 2 articles (01/2011 - 07/2009)
2. Hardwicke, Mary Ann: 2 articles (01/2011 - 07/2009)
3. Plant, Ramona: 2 articles (01/2011 - 07/2009)
4. Locatelli, Franco: 1 article (01/2014)
5. Bressanin, Daniela: 1 article (01/2014)
6. Evangelisti, Cecilia: 1 article (01/2014)
7. Pession, Andrea: 1 article (01/2014)
8. Cappellini, Alessandra: 1 article (01/2014)
9. Lonetti, Annalisa: 1 article (01/2014)
10. Spartà, Antonino Maria: 1 article (01/2014)

Related Diseases

1. Neoplasms (Cancer)
2. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
3. Leukemia

Related Drugs and Biologics

1. Biological Markers (Surrogate Marker)
2. Serine (L-Serine)
3. Phosphotransferases (Kinase)
4. Histones (Histone)
5. 4- (3- chloro- 2- fluorophenoxy)- 1- ((6- (1,3- thiazol- 2- ylamino)pyridin to 2-yl)methyl) cyclohexanecarboxylic acid
6. aurora kinase (aurora A kinase)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)